The Vanguard Group 13D and 13G filings for Cullinan Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 2:23 pm Unchanged |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 2,998,714 5.170% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:18 am Purchase |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 2,998,714 5.170% |
1,227,271 (+69.28%) |
Filing |
| 2024-02-13 5:02 pm Sale |
2023-12-29 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 1,771,443 4.140% |
-1,041,522 (-37.03%) |
Filing |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 2,812,965 6.150% |
446,157 (+18.85%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
The Vanguard Group | 2,366,808 5.420% |
2,366,808 (New Position) |
Filing |